Literature DB >> 8240267

Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors.

Y Chen1, A Mestek, J Liu, L Yu.   

Abstract

By screening a rat brain cDNA library using a cloned mu opioid receptor cDNA as probe, a clone was identified that is very similar to both the mu and delta opioid receptor sequences. Transient expression of this clone in COS-7 cells showed that it encodes a kappa opioid receptor, designated KOR-1, which is capable of high-affinity binding to kappa-selective ligands. Treatment of transfected cell membranes with bremazocine, a kappa-selective agonist, resulted in a 53% decrease in adenylate cyclase activity, indicating that this kappa opioid receptor displays inhibitory coupling to adenylate cyclase. Thus, one member from each of the three opioid receptor types, mu, kappa and delta, has been molecularly cloned. Analysis of sequence similarities among these opioid receptors, as well as between opioid receptors and other G-protein-coupled receptors, revealed regions of sequence conservation that may underlie the ligand-binding and functional specificities of opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240267      PMCID: PMC1134603          DOI: 10.1042/bj2950625

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Expression cloning of a rat brain somatostatin receptor cDNA.

Authors:  F W Kluxen; C Bruns; H Lübbert
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Cloning of a delta opioid receptor by functional expression.

Authors:  C J Evans; D E Keith; H Morrison; K Magendzo; R H Edwards
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

Review 3.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

4.  Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitylated.

Authors:  N G Abdulaev; A S Bogachuk
Journal:  FEBS Lett       Date:  1988-03-28       Impact factor: 4.124

5.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

6.  Identification of residues required for ligand binding to the beta-adrenergic receptor.

Authors:  C D Strader; I S Sigal; R B Register; M R Candelore; E Rands; R A Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.

Authors:  K Yasuda; K Raynor; H Kong; C D Breder; J Takeda; T Reisine; G I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

8.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

9.  Molecular cloning and functional expression of a mu-opioid receptor from rat brain.

Authors:  Y Chen; A Mestek; J Liu; J A Hurley; L Yu
Journal:  Mol Pharmacol       Date:  1993-07       Impact factor: 4.436

10.  Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor.

Authors:  J L Benovic; R H Strasser; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more
  52 in total

1.  Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration.

Authors:  T P Piepponen; J A Mikkola; M Ruotsalainen; D Jonker; L Ahtee
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  G-protein coupling of mu-opioid receptors (OP3): elevated basal signalling activity.

Authors:  N T Burford; D Wang; W Sadée
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

Review 3.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

4.  Splice variation of the mu-opioid receptor and its effect on the action of opioids.

Authors:  Sophy K Gretton; Joanne Droney
Journal:  Br J Pain       Date:  2014-11

5.  A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist.

Authors:  Nidhi Singh; Gwénaël Chevé; David M Ferguson; Christopher R McCurdy
Journal:  J Comput Aided Mol Des       Date:  2006-09-29       Impact factor: 3.686

Review 6.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

7.  Computational study of the heterodimerization between mu and delta receptors.

Authors:  Xin Liu; Ming Kai; Lian Jin; Rui Wang
Journal:  J Comput Aided Mol Des       Date:  2009-02-13       Impact factor: 3.686

Review 8.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 9.  Regulation of male fertility by the opioid system.

Authors:  Nerea Subirán; Luis Casis; Jon Irazusta
Journal:  Mol Med       Date:  2011-03-16       Impact factor: 6.354

10.  Affinity labeling mu opioid receptors with novel radioligands.

Authors:  Ke Yang; Amy Zuckerman; Gavril W Pasternak
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.